Stay updated on Daratumumab in Bortezomib Combo for Myeloma Clinical Trial
Sign up to get notified when there's something new on the Daratumumab in Bortezomib Combo for Myeloma Clinical Trial page.

Latest updates to the Daratumumab in Bortezomib Combo for Myeloma Clinical Trial page
- Check2 days agoChange DetectedThe page’s visible revision/version label was updated from v3.5.2 to v3.5.3, indicating a site release update rather than any modification to the clinical trial’s record history.SummaryDifference0.0%

- Check9 days agoChange DetectedAdded revision v3.5.2 to the record history and removed revision v3.5.0.SummaryDifference0.0%

- Check16 days agoNo Change Detected
- Check38 days agoChange DetectedAdded Revision: v3.5.0 and removed Revision: v3.4.3 from the page.SummaryDifference0.0%

- Check45 days agoChange DetectedRevision label updated from v3.4.2 to v3.4.3 on the page header. This is a minor UI update with no impact on study data.SummaryDifference0.0%

- Check75 days agoChange DetectedA new site revision entry (Revision: v3.4.2) was added, and older notices (the funding lapse notice and Revision: v3.4.1) were removed.SummaryDifference0.3%

- Check82 days agoChange DetectedA system-wide notice about funding status and the NIH Clinical Center's status was added, and the page revision updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

Stay in the know with updates to Daratumumab in Bortezomib Combo for Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Daratumumab in Bortezomib Combo for Myeloma Clinical Trial page.